Choosing the right cell line for breast cancer research

DL Holliday, V Speirs - Breast cancer research, 2011 - Springer
Breast cancer is a complex and heterogeneous disease. Gene expression profiling has
contributed significantly to our understanding of this heterogeneity at a molecular level …

Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids

JF Dekkers, EJ van Vliet, N Sachs, JM Rosenbluth… - Nature protocols, 2021 - nature.com
Organoid technology has revolutionized the study of human organ development, disease
and therapy response tailored to the individual. Although detailed protocols are available for …

A living biobank of breast cancer organoids captures disease heterogeneity

N Sachs, J De Ligt, O Kopper, E Gogola, G Bounova… - Cell, 2018 - cell.com
Breast cancer (BC) comprises multiple distinct subtypes that differ genetically,
pathologically, and clinically. Here, we describe a robust protocol for long-term culturing of …

Identification of gastric cancer stem cells using the cell surface marker CD44

S Takaishi, T Okumura, S Tu, SSW Wang… - Stem …, 2009 - academic.oup.com
Cancer stem cells (CSCs) have been defined as a unique subpopulation in tumors that
possess the ability to initiate tumor growth and sustain tumor self-renewal. Although the …

Biomimetic nanotechnology toward personalized vaccines

J Zhou, AV Kroll, M Holay, RH Fang… - Advanced …, 2020 - Wiley Online Library
While traditional approaches for disease management in the era of modern medicine have
saved countless lives and enhanced patient well‐being, it is clear that there is significant …

[HTML][HTML] Histological types of breast cancer: how special are they?

B Weigelt, FC Geyer, JS Reis-Filho - Molecular oncology, 2010 - Elsevier
Breast cancer is a heterogeneous disease, comprising multiple entities associated with
distinctive histological and biological features, clinical presentations and behaviours and …

Three-dimensional printing of Hela cells for cervical tumor model in vitro

Y Zhao, R Yao, L Ouyang, H Ding, T Zhang… - …, 2014 - iopscience.iop.org
Advances in three-dimensional (3D) printing have enabled the direct assembly of cells and
extracellular matrix materials to form in vitro cellular models for 3D biology, the study of …

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

J Kao, K Salari, M Bocanegra, YL Choi, L Girard… - PloS one, 2009 - journals.plos.org
Background Breast cancer cell lines have been used widely to investigate breast cancer
pathobiology and new therapies. Breast cancer is a molecularly heterogeneous disease …

[HTML][HTML] The past, present, and future of breast cancer models for nanomedicine development

P Boix-Montesinos, PM Soriano-Teruel… - Advanced drug delivery …, 2021 - Elsevier
Even given recent advances in nanomedicine development of breast cancer treatment in
recent years and promising results in pre-clinical models, cancer nanomedicines often fail at …

Progress in the understanding of the mechanism of tamoxifen resistance in breast cancer

J Yao, K Deng, J Huang, R Zeng, J Zuo - Frontiers in pharmacology, 2020 - frontiersin.org
Tamoxifen is a drug commonly used in the treatment of breast cancer, especially for
postmenopausal patients. However, its efficacy is limited by the development of drug …